Refractory Non-Hodgkin's lymphoma Recruiting Phase 1 / 2 Trials for Aldesleukin (DB00041)

Also known as: Refractory Non Hodgkin Lymphoma / Refractory Non-Hodgkin Lymphoma / Refractory Non-Hodgkin Lympoma / Refractory Non-Hodgkin-Lymphoma / Non-Hodgkin's lymphoma refractory / Non-Hodgkin's lymphoma NOS refractory

IndicationStatusPhase
DBCOND0024997 (Refractory Non-Hodgkin's lymphoma)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03778619MG4101 Plus Rituximab Including Lymphodepletion in Patient With r/r NHL B-cell OriginTreatment